Redcare Pharmacy NV (XTER:RDC)
€ 135.9 -1.6 (-1.16%) Market Cap: 2.70 Bil Enterprise Value: 2.76 Bil PE Ratio: 0 PB Ratio: 5.38 GF Score: 79/100

Q3 2022 Shop Apotheke Europe NV Earnings Call Transcript

Oct 31, 2022 / 10:00AM GMT
Stefan Feltens
Shop Apotheke Europe NV - CEO

Well, good morning, everybody. Jasper and I would like to welcome you to the release of Shop Apotheke -- Shop Apotheke Europe's full Q3 financials. To start with the end in mind, against the backdrop -- as we're all witnessing this, of difficult and challenging economic times and many uncertainties everybody is facing right now, I dare to say that Shop Apotheke delivered a solid quarter which was fully in line with the guidance we had provided earlier this year.

Talking about the guidance, Shop Apotheke's management continues to stand behind this guidance and the guidance at the end of our call will be reiterated by Jasper one more time.

Well, you see the usual agenda, we're going to start with a deep dive into our Q3 performance, and then we just have, literally, a couple of charts on e-prescriptions in Germany and Shop Apotheke's commitment to sustainable development. And at the very end, rest assured, we're going to have plenty of time to answer any questions that you might have.

So let's start with a deep dive into Q3. At the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot